scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1036257776 |
P356 | DOI | 10.1186/CC7990 |
P932 | PMC publication ID | 2750187 |
P698 | PubMed publication ID | 19664253 |
P5875 | ResearchGate publication ID | 26726135 |
P50 | author | Hugo Van Aken | Q14508140 |
P2093 | author name string | Alessandra Orecchioni | |
Andrea Morelli | |||
Paolo Pietropaoli | |||
Matthias Lange | |||
Christian Ertmer | |||
Martin Westphal | |||
Sebastian Rehberg | |||
Mariadomenica D'Alessandro | |||
Alessandra Bachetoni | |||
Valeria Cecchini | |||
P2860 | cites work | Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study | Q46691567 |
Septic shock--vasopressin, norepinephrine, and urgency | Q46729640 | ||
Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock | Q46944278 | ||
Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver | Q46965282 | ||
Continuous versus bolus infusion of terlipressin in ovine endotoxemia | Q50070883 | ||
Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. | Q50736316 | ||
Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. | Q52096231 | ||
Monitoring gastric mucosal carbon dioxide pressure using gas tonometry: in vitro and in vivo validation studies. | Q52897666 | ||
Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. | Q54147261 | ||
Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine | Q68342642 | ||
Renal microvascular effects of vasopressin and vasopressin antagonists | Q69946506 | ||
Physiologic concentrations of arginine vasopressin activate human platelets in vitro | Q71045277 | ||
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients | Q78500306 | ||
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better? | Q80387730 | ||
The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock | Q81251480 | ||
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group | Q21195082 | ||
Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 | Q29615602 | ||
Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock | Q33195919 | ||
Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? | Q33361871 | ||
Pressure diuresis and hypertension | Q34060492 | ||
The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series | Q34340908 | ||
Physiology of vasopressin relevant to management of septic shock | Q34368620 | ||
Vasopressin versus norepinephrine infusion in patients with septic shock. | Q34756330 | ||
Arginine vasopressin in 316 patients with advanced vasodilatory shock. | Q36308724 | ||
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport | Q40565104 | ||
Splanchnic tonometry: a review of physiology, methodology, and clinical applications | Q40644370 | ||
Concomitant stimulation by vasopressin of biliary and perfusate calcium fluxes in the perfused rat liver | Q41906307 | ||
Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial | Q43412778 | ||
Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis | Q43449088 | ||
Beneficial effects of short-term vasopressin infusion during severe septic shock | Q43901842 | ||
Terlipressin for norepinephrine-resistant septic shock | Q43960661 | ||
Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study | Q44430966 | ||
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock | Q44496952 | ||
Terlipressin Infusion in Catecholamine-resistant Shock | Q44644649 | ||
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study | Q44969515 | ||
Terlipressin in catecholamine-resistant septic shock patients | Q45065789 | ||
Vasopressin plus corticosteroids: the shock duo! | Q46111931 | ||
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. | Q46111974 | ||
P433 | issue | 4 | |
P921 | main subject | sepsis | Q183134 |
septic shock | Q1765564 | ||
AVP | Q12009087 | ||
P304 | page(s) | R130 | |
P577 | publication date | 2009-08-10 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study | |
P478 | volume | 13 |
Q97529284 | A Furosemide Excretion Stress Test Predicts Mortality in Mice After Sepsis and Outperforms the Furosemide Stress Test During Vasopressin Administration |
Q36384718 | A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock |
Q51501472 | A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock. |
Q88816305 | Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis |
Q36070556 | Bench-to-bedside review: Vasopressin in the management of septic shock |
Q64126295 | Challenges in the management of septic shock: a narrative review |
Q35106625 | Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: a meta-analysis |
Q91741502 | Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials |
Q64055906 | Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials |
Q57736170 | Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysis |
Q55036665 | Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock. |
Q42907348 | Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock |
Q37910252 | Current management of sepsis in critically ill adult patients |
Q46440550 | Current place of vasopressin analogues in the treatment of septic shock |
Q35215743 | Effects of terlipressin as early treatment for protection of brain in a model of haemorrhagic shock |
Q43601541 | Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia |
Q35908131 | Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock |
Q40655602 | Epidemiology of Vasopressin Use for Adults with Septic Shock. |
Q90665537 | Evaluation of Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Glomerular Filtration Rate and Amikacin Clearance During Early Rat Endotoxemia: Comparison with Traditional Endogenous and Exogenous Biomarkers |
Q40147443 | Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy |
Q44899872 | Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison |
Q26777564 | Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials |
Q91795118 | Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review |
Q48177394 | Perioperative assessment of terlipressin infusion during living donor liver transplantation |
Q38272554 | Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit |
Q35559191 | Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review |
Q36980868 | Right heart in septic shock: prospective observational study |
Q33752658 | Role of vasopressin in current anesthetic practice |
Q34047325 | Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure |
Q36454207 | Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis |
Q41414669 | Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. |
Q90446344 | Shock - Classification and Pathophysiological Principles of Therapeutics |
Q44840415 | Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock |
Q38433744 | Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. |
Q29615429 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 |
Q92535791 | Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis |
Q64103730 | Terlipressin for septic shock patients: a meta-analysis of randomized controlled study |
Q90076363 | Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis |
Q42115488 | Terlipressin or europressin? |
Q93064285 | Terlipressin or norepinephrine in septic shock: do we have the answer? |
Q90153140 | Terlipressin or norepinephrine, or both in septic shock? |
Q89414740 | Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial |
Q64087927 | Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension |
Q87791624 | The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016) |
Q50052469 | The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). |
Q64092466 | The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis |
Q34166143 | The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis |
Q37831209 | The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature |
Q38154892 | Therapeutic strategies for high-dose vasopressor-dependent shock. |
Q35658313 | Translational research in sepsis - an ultimate challenge? |
Q54254903 | Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. |
Q47355759 | Use of Terlipressin in an Elderly Patient With Moderate Aortic Valve Stenosis Accompanied by Episodic Atrial Fibrillation During Liver Transplantation: A Case Report |
Q36147248 | Use of inotropes and vasopressor agents in critically ill patients. |
Q55004378 | Using terlipressin in a pediatric patient with septic shock resistant to catecholamines. |
Q28068818 | Vasoactive agents for the treatment of sepsis |
Q50245134 | Vasomotor tone and CBP : monitoring components, pratical and therapeutic approaches |
Q52372060 | Vasoplegia treatments: the past, the present, and the future. |
Q26823378 | Vasopressin V1a and V1b receptors: from molecules to physiological systems |
Q21195136 | Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials |
Q37962808 | Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis |
Q58205736 | Vasopressin improves systemic hemodynamics without compromising mesenteric perfusion in the resuscitation of asphyxiated newborn piglets: a dose–response study |
Q64910237 | Vasopressin in Pediatric Critical Care. |
Q24186138 | Vasopressors for hypotensive shock |
Q24234415 | Vasopressors for hypotensive shock |
Q26799763 | Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis |
Q35707635 | Vasopressors in septic shock: a systematic review and network meta-analysis |
Q37814495 | Year in review 2009: Critical Care--shock |
Q87899631 | [Role of vasopressin in septic shock : critical evaluation] |
Search more.